ArticleUnited European gastroenterology journal2017

Use of inhibitors of the renin-angiotensin system is associated with longer survival in patients with hepatocellular carcinoma.

Matthias Pinter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.